Piramal, Pharma

Piramal Pharma Ltd. Continues to Invest In USA; $90M in Expansions of Two US Sites

Published on 08/07/2025 at 18:08 | prnewswire.co.uk

Piramal Pharma Ltd Italy United States of America Canada Spain Germany France India

Addition of commercial-scale sterile injectables capabilities in Lexington, KYAddition of development and commercial-scale capabilities in payload-linkers for bioconjugates in Riverview, MIThis is incremental to Piramal's prior investments of $570 M in the US| LinkedIn

* Includes one facility via PPL's minority investment in Yapan Bio.

Photo: https://mma.prnewswire.com/media/2685022/Peter_DeYoung_CEO_Piramal.jpg
Photo: https://mma.prnewswire.com/media/2685019/New_Lexington_facility.jpg
Photo: https://mma.prnewswire.com/media/2685018/Riverview_site_expansion.jpg
Logo: https://mma.prnewswire.com/media/1855206/4913155/Piramal_Pharma_Limited_Logo.jpg

 

Rendering of the new Lexington sterile fill/finish facility

 

Riverview site, expansion building featured at left

 

Piramal_Pharma_Limited_Logo

 

 

Cision View original content:https://www.prnewswire.co.uk/news-releases/piramal-pharma-ltd-continues-to-invest-in-usa-90m-in-expansions-of-two-us-sites-302452450.html

en | boerse | 67927869 |